| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,193 |
17,561 |
$636K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,154 |
6,950 |
$446K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,746 |
8,166 |
$404K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,172 |
7,642 |
$312K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,293 |
3,053 |
$280K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,793 |
3,511 |
$187K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
440 |
420 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,686 |
1,617 |
$24K |
| 87634 |
|
241 |
221 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,086 |
521 |
$15K |
| H0033 |
Oral medication administration, direct observation |
448 |
419 |
$8K |
| 87631 |
|
54 |
54 |
$6K |
| 81002 |
|
2,270 |
2,151 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
245 |
230 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
152 |
148 |
$3K |
| 99000 |
|
1,036 |
982 |
$1K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
284 |
222 |
$857.69 |
| 36415 |
Collection of venous blood by venipuncture |
284 |
268 |
$715.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29 |
28 |
$684.62 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
71 |
53 |
$307.65 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
77 |
71 |
$47.70 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
27 |
$46.49 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
15 |
15 |
$5.85 |
| 99072 |
|
135 |
121 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
70 |
51 |
$0.00 |